Global Smart Biopsy Devices Market 2022-2028

May 2022 | 65 pages | ID: G3163D6A3068EN
Gen Consulting Company

Abstracts

A biopsy is a diagnostic procedure where a tissue or cell sample is removed and then examined under a microscope. Biopsies are commonly used to determine whether a tumor or growth is cancerous or non-cancerous (benign). Smart biopsies allow real-time cancer tissue characterization and have been developed and are already being used in some hospitals to accelerate cancer diagnosis. According to Gen Consulting Company, the global smart biopsy devices market is projected to reach USD 3,552 million, recording a CAGR of approximately 4.3 percent from 2022 to 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart biopsy devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart biopsy devices industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for smart biopsy devices can be segmented by application: breast cancer, prostate cancer, skin cancer, liver cancer, others. Smart biopsy devices market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.

By application:

• breast cancer
• prostate cancer
• skin cancer
• liver cancer
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides a detailed analysis of several leading smart biopsy devices market vendors that include Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corp., Canon Medical Systems Corporation, Hologic Inc., innoMedicus Ltd., Planmed Oy, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global smart biopsy devices market.
• To classify and forecast the global smart biopsy devices market based on application, region.
• To identify drivers and challenges for the global smart biopsy devices market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global smart biopsy devices market.
• To identify and analyze the profile of leading players operating in the global smart biopsy devices market.

Why Choose This Report

• Gain a reliable outlook of the global smart biopsy devices market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY APPLICATION

Breast cancer
Prostate cancer
Skin cancer
Liver cancer
Others

PART 6. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 7. KEY COMPANIES

Argon Medical Devices, Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corp.
Canon Medical Systems Corporation
Hologic Inc.
innoMedicus Ltd.
Planmed Oy
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER